Merck Tbk. vs Sari Kreasi Boga Tbk. — how do they compare? Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume), while Sari Kreasi Boga Tbk. trades at Rp36 (market cap 115.74B, 1.83M 24h volume). The key difference: Merck Tbk. is far larger — about 15.2× Sari Kreasi Boga Tbk.'s market cap, and Sari Kreasi Boga Tbk. is more actively traded (1.83M versus 63K). Which is the better fit depends on your goals.
| MERK | RAFI | |
|---|---|---|
Market Cap | 1.76T | 115.74B |
Volume | 63K | 1.83M |
Lot | 630 | 18.26K |
Turnover | 243.97M | — |
Average Price | 3,872.46 | — |
Value | 243.97M | — |
Indicative Equilibrium Price | 3,900 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Sari Kreasi Boga Tbk (the Company) was established based on Deed No. 29 dated July 17, 2017 made before Notary Mahendra Adinegara, S.H., M.Kn. in Jakarta.
Read more on RAFI →